If approved, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind currently on the U.S. market after Leqembi from Biogen and Eisai.

Longer-term data show that donanemab’s cognitive benefits continue to grow over time, and earlier initiation reduces the risk for progression, with no new safety signals.

New medications for Alzheimer’s disease – which are not yet approved in some countries – have shown for the first time that clinical decline can be slowed with comparable effectiveness to approved med...

Dr Kamar Ameen-Ali explores the overlooked link between delirium and dementia, highlighting risks, misdiagnosis, and the urgent need for more research.

Dr Peter Connelly on balancing clinical research with a clinical career, showing how small steps can make research part of everyday practice.

Special Collection: Explore blogs, podcasts and webinars where researchers share their lives, journeys, and diverse paths into research careers

What if the earliest signs of pancreatic cancer looked eerily similar to what happens in the brain during dementia? That’s the provocative question raised by new research from the Cancer Research UK Scotland Centre, where scientists have uncovered a startling biological overlap between two seemingly unrelated diseases. In a study published in Developmental Cell, researchers tracked pancreatic cells in mice to understand how normal cells begin their transformation into cancer.

New EMPOWER Dementia Network+ Toolkit offers practical guidance, case studies and resources to support genuine co-production with people living with dementia.

Regular volunteering or helping others outside the home can reduce the rate of cognitive aging by 15-20%.

I’ve been living in the pain and trauma of having to move my husband to memory care.  It has been a difficult time these past two months.  We’ve both struggled through the adjustment to our lives.  He...

YouTube video by Peter Gabriel

The comedy legend tours the UK this September

A Finnish population study shows that signs related to Alzheimer’s disease may already be found in the brain in middle age. In the future, blood-based biomarkers associated with Alzheimer's disease co...

Two new studies of former rugby players, involving UCL researchers, found no cases of early-onset dementia but did find potential signs of increased risk of developing dementia later on.

Who gets left out of dementia prevention efforts? Dr Jodi Watt highlights how social inequity shapes risk and why we must rethink prevention for everyone.